tech cryptocurrency, People also ask

[The time is ripe for Shanghai stocks to become monsters in batches! 】After-hours big profits are related to mergers and acquisitions, restructuring, Shanghai state-owned shares have these.It is worth mentioning that among the stocks with a market value of less than 10 billion yuan, Kaikai Industry, Fudan Fuhua, First Hospital and Xuantai Medicine all belong to the biomedical industry. Among the state-owned shares in Shanghai, Hua Hong Company and Hehui Optoelectronics -U belong to the semiconductor industry.

Judging from the market performance, the average growth rate of 41 key sector stocks since September 18 is close to 56%, far outperforming the performance of the broader market in the same period. Among them, two stocks of Xinxiangwei and SMIC doubled. Xinxiangwei's main business focuses on the research, development, design and sales of display chips, and is committed to providing complete display chip system solutions.Judging from the market performance, the average growth rate of 41 key sector stocks since September 18 is close to 56%, far outperforming the performance of the broader market in the same period. Among them, two stocks of Xinxiangwei and SMIC doubled. Xinxiangwei's main business focuses on the research, development, design and sales of display chips, and is committed to providing complete display chip system solutions.In the secondary market, the concept stocks of M&A and restructuring rose strongly, and the restructuring index rose nearly 63% since September 24th.

Shanghai state-owned shares have these.The stagflation stocks mainly include Haohaishengke, Shanghai Laishi and Weir. Among them, Haohai Shengke increased by less than 10%. The company is a scientific and technological innovative enterprise that applies biomedical materials technology and genetic engineering technology to research, develop, produce and sell medical devices and drugs. It is committed to providing innovative medical products for the market through technological innovation and transformation, integration of domestic and foreign resources and large-scale production, and gradually realizing the import substitution of related medical products, thus becoming a leading enterprise in the field of biomedical materials.The action plan proposes that by 2027, we will strive to land a number of representative M&A cases in key industries, and cultivate about 10 internationally competitive listed companies in key industries such as integrated circuits, biomedicine and new materials, forming a scale of M&A transactions of 300 billion yuan and activating total assets of over 2 trillion yuan; Gather 3-5 professional M&A fund managers with strong industry influence, and the M&A service ability of intermediaries has been greatly improved, and the M&A service platform has played an active role; The joint efforts of the city, urban areas, government and enterprises have been significantly strengthened, and the policy guarantee system has made concerted efforts to build Shanghai into a pioneering area and demonstration area for mergers and acquisitions of listed companies with significantly improved industrial level, more sound M&A ecology and diversified and long-term cooperation mechanism, so as to better serve the high-quality development of the economy.